Literature DB >> 12682642

Intramuscular edema as a complication of treatment with imatinib.

C Shimazaki, N Ochiai, R Uchida, S-I Fuchida, A Okano, E Ashihara, T Inaba, N Fujita, M Nakagawa.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12682642     DOI: 10.1038/sj.leu.2402868

Source DB:  PubMed          Journal:  Leukemia        ISSN: 0887-6924            Impact factor:   11.528


× No keyword cloud information.
  5 in total

1.  Effect of platelet-derived growth factor receptor-beta inhibition with STI571 on radioimmunotherapy.

Authors:  Janina Baranowska-Kortylewicz; Michio Abe; Kristian Pietras; Zbigniew P Kortylewicz; Takashi Kurizaki; Jessica Nearman; Janna Paulsson; R Lee Mosley; Charles A Enke; Arne Ostman
Journal:  Cancer Res       Date:  2005-09-01       Impact factor: 12.701

Review 2.  [Medically induced myopathia].

Authors:  J Finsterer
Journal:  Nervenarzt       Date:  2006-06       Impact factor: 1.214

Review 3.  From Molecular Mechanisms to Clinical Management of Antineoplastic Drug-Induced Cardiovascular Toxicity: A Translational Overview.

Authors:  Carlo Gabriele Tocchetti; Christian Cadeddu; Daniela Di Lisi; Saveria Femminò; Rosalinda Madonna; Donato Mele; Ines Monte; Giuseppina Novo; Claudia Penna; Alessia Pepe; Paolo Spallarossa; Gilda Varricchi; Concetta Zito; Pasquale Pagliaro; Giuseppe Mercuro
Journal:  Antioxid Redox Signal       Date:  2017-05-15       Impact factor: 8.401

4.  Rhabdomyolysis associated with fenofibrate monotherapy in a patient with chronic myelogenous leukemia.

Authors:  Kazuya Kato; Astushi Nagase; Minoru Matsuda; Yurina Kato; Kazuhiko Onodera; Takako Kawakami; Mineko Higuchi; Yoshiaki Iwasaki; Masahiko Taniguchi; Hiroyuki Furukawa
Journal:  Case Rep Gastroenterol       Date:  2011-08-27

5.  Nilotinib impairs skeletal myogenesis by increasing myoblast proliferation.

Authors:  Osvaldo Contreras; Maximiliano Villarreal; Enrique Brandan
Journal:  Skelet Muscle       Date:  2018-02-20       Impact factor: 4.912

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.